NCT03916601 - Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

March 22, 2018

Study Completion Date

March 22, 2018

Conditions

Type 1 Diabetes

Interventions

DRUG

SAR341402

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

Insulin Aspart

"Pharmaceutical form: suspension for injection~Route of administration: subcutaneous"

DRUG

Insulin Aspart

"Pharmaceutical form: suspension for injection~Route of administration: subcutaneous"

DRUG

SAR341402

"Pharmaceutical form: suspension for injection~Route of administration: subcutaneous"

Trial Locations (1)

Investigational Site Number 2760001, Neuss